Matches in Nanopublications for { ?s ?p "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP497802.RACVKDv0N5wCfdB67-8o3IluE31xvgtkS_ckgrH8bSkgw130_assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497802.RACVKDv0N5wCfdB67-8o3IluE31xvgtkS_ckgrH8bSkgw130_provenance.
- NP522311.RAxIPMcLIdshle4rnNq1bKx46rCkj0Vj-64tF8KbIbwoM130_assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522311.RAxIPMcLIdshle4rnNq1bKx46rCkj0Vj-64tF8KbIbwoM130_provenance.
- NP913736.RAblAJ_2UVKvIkby-Elgyl-NfXcnz4xKi9sBdziYwcOR4130_assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913736.RAblAJ_2UVKvIkby-Elgyl-NfXcnz4xKi9sBdziYwcOR4130_provenance.
- assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP825792.RANOx6mBHS0EIQpi9r7DPJNc7279mnlIsmSY27PZknwgg130_assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825792.RANOx6mBHS0EIQpi9r7DPJNc7279mnlIsmSY27PZknwgg130_provenance.
- NP1013853.RAtsI0nhNnP7KYbZEHMY1r9FQNzq0CKVJYgOP0pvnTjmc130_assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013853.RAtsI0nhNnP7KYbZEHMY1r9FQNzq0CKVJYgOP0pvnTjmc130_provenance.
- NP913718.RAE7EqznbTHC0yx6brOZQEb2g5PkGtw4_G3Ths6i10tuc130_assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913718.RAE7EqznbTHC0yx6brOZQEb2g5PkGtw4_G3Ths6i10tuc130_provenance.
- NP913734.RAJLqnzF8Qm1PdcK8HIKyW5wMSh_AW1TJqxBjlqebdMHI130_assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913734.RAJLqnzF8Qm1PdcK8HIKyW5wMSh_AW1TJqxBjlqebdMHI130_provenance.
- NP913710.RAwccKnxqazqr21by1LR7NGFcnBAMTCDr6g4qvUHkCd2U130_assertion description "[LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913710.RAwccKnxqazqr21by1LR7NGFcnBAMTCDr6g4qvUHkCd2U130_provenance.